4576.T
D.Western Therapeutics Institute, Inc.
グロース · 医薬品 · 医薬品 · JP
JPY 85.00
−1.16%Year over year
Reported trailing growth
- Revenue
- -17.8%
- EBITDA
- —
- EBIT
- +48.8%
- EPS
- +63.8%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +3.4%
- EBITDA
- —
- EPS
- -14.4%
Three-year CAGR
- Revenue
- -4.8%
- EBITDA
- +50.7%
- EBIT
- +48.8%
- Net income
- +51.0%
- EPS
- +64.1%
- Free cash flow
- +62.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026